CorriXR Therapeutics, Inc.

Biotechnology company · Newark, Delaware, United States

CorriXR Therapeutics, Inc. is a biotechnology company headquartered in Newark, Delaware, United States. Its earliest recorded incorporation is in 2022. It has reported private securities offerings to the US SEC, most recently $6.5 million sold in a notice filed in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

CorriXR Therapeutics at a glance

Typebiotechnology company

HeadquartersNewark, Delaware, United States

Earliest incorporation on record2022

SEC CIK1938281

What does CorriXR Therapeutics do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $6.5 million sold (2024).

Frequently asked questions about CorriXR Therapeutics

Where is CorriXR Therapeutics headquartered?

CorriXR Therapeutics, Inc. is headquartered in Newark, Delaware, United States.

What does CorriXR Therapeutics do?

CorriXR Therapeutics, Inc. is a biotechnology company.

When was CorriXR Therapeutics founded?

The earliest incorporation on record for CorriXR Therapeutics, Inc. is in 2022, according to public company registers.

Similar companies

Toivoa, IncNewark, Delaware, United States
Cell Podium LLCNewark, New Jersey, United States
Virion Therapeutics, LLCNewark, Delaware, United States
Simphotek, Inc.Newark, New Jersey, United States
Fauna Bio IncorporatedNewark, California, United States
Kaneka Americas Holding IncNewark, California, United States
Koi Biotherapeutics Inc.Newark, Delaware, United States
Nangiotx IncNewark, New Jersey, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences